Generally, ages ≥50 years were associated with an increased risk; a clear trend was observed in 19 cohorts, with the strongest evidence in the levothyroxine cohort for warfarin concomitance (aORs 2.75 [95% CI 2.10-3.61], 6.99 [95% CI 5.38-9.07], and 11.26 [95% CI 8.66-14.63] in the three age groups, respectively, vs the <50 years class).
1
—
—